Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
The company has been in a very positive evolution with new CEO and mix of new and existing leadership team. Clear commitment to strong and positive culture, people, patients and results.
Qual è la parte migliore del tuo compenso?
Fair evaluation of goals and receipt of bonus
Che cosa ti rende più felice sul posto di lavoro?
trial results that focus on patients
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
actively being evolved with clear commitment to people, teams and patients
Cosa ti piace di più del team di leadership?
Actively evolved from past control and command to engaged, aligned and capable team!!
Quali sono alcune delle cose migliori della tuo team?
Increasingly aligned and capable with a strong commitment to work together and lack of politics
Other Employee Reviews for Karyopharm Therapeutics
×